The virtual international stroke trials archive (vista): Results and impact on future stroke trials and management of stroke patients

International Journal of Stroke

Volumn 5, Issue 2, 2010, Pages 103-109

  Weimar, C ^a   Ali, M ^b   Lees, K R ^b   Bluhmki, E ^c   Donnan, G A ^d   Diener, H C ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b WESTERN INFIRMARY   (United Kingdom)

^c BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

^d UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Clinical trials; Database; Outcome; Predictors; Stroke

Indexed keywords

4 PHOSPHONOMETHYLPIPECOLIC ACID; ALTEPLASE; ANCROD; CLOMETHIAZOLE; DISUFENTON SODIUM; GAVESTINEL; LUBELUZOLE; MAGNESIUM SULFATE; NIMODIPINE; REPINOTAN; STREPTOKINASE; TINZAPARIN; URATE;

ACCESS TO INFORMATION; ARTICLE; BRAIN HEMORRHAGE; BRAIN INFECTION; BRAIN ISCHEMIA; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONVALESCENCE; DATA ANALYSIS; DECOMPRESSION SURGERY; DISEASE COURSE; DISEASE REGISTRY; EXPLORATORY RESEARCH; FUNCTIONAL ASSESSMENT; HEALTH CARE QUALITY; HEMISPHERIC DOMINANCE; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; HYPERTHERMIA; INFORMATION PROCESSING; INTRACARDIAC THROMBOSIS; MEDICAL INFORMATION; MEDICAL RECORD; MEDICAL RESEARCH; METHODOLOGY; MORBIDITY; MORTALITY; NEUROSURGERY; OCCLUSIVE CEREBROVASCULAR DISEASE; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RACE DIFFERENCE; SYSTOLIC BLOOD PRESSURE;

ANTICOAGULANTS; ARCHIVES; CLINICAL TRIALS AS TOPIC; FIBRINOLYTIC AGENTS; FORECASTING; HUMANS; HYPERTHERMIA, INDUCED; NEUROPROTECTIVE AGENTS; PATIENT SELECTION; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STROKE; USER-COMPUTER INTERFACE;

EID: 77951265095     PISSN: 17474930     EISSN: 17474949     Source Type: Journal    
DOI: 10.1111/j.1747-4949.2010.00414.x     Document Type: Article

References (53)

1. Ali M, Bath PM, Curram J. The Virtual International Stroke Trials Archive. Stroke 2007, 38:1905-10.
2. Diener HC, Kaste M, Hacke W. Lubeluzole in acute ischemic stroke: international trial. J Neurol Sci 1997, 150:S273-82.
3. Sherman DG, Atkinson RP, Chippendale T. Intravenous ancrod for treatment of acute ischemic stroke: the STAT study: a randomized controlled trial. Stroke treatment with ancrod trial. JAMA 2000, 283:2395-403.
4. Diener HC. Multinational randomised controlled trial of lubeluzole in acute ischaemic stroke. Cerebrovasc Dis 1998, 8:172-81. for the European and Australian Lubeluzole Ischaemic Stroke Study Group.
5. Hennerici MG, Kay R, Bogousslavsky J, Lenzi GL, Verstraete M, Orgogozo JM. Intravenous ancrod for acute ischaemic stroke in the European stroke treatment with ancrod trial: a randomised controlled trial. Lancet 2006, 368:1871-8.
6. Diener HC, Cortens M, Ford G. Lubeluzole in acute ischemic stroke treatment: a double-blind study with an 8-hour inclusion window comparing a 10 mg daily dose of lubeluzole with placebo. Stroke 2000, 31:2543-51.
7. Donnan GA, Davis SM, Chambers BR. Streptokinase for acute ischemic stroke with relationship to time of administration: Australian Streptokinase (ASK) Trial Study Group. JAMA 1996, 276:961-6.
8. Lyden P, Shuaib A, Ng K. Clomethiazole acute stroke study in ischemic stroke (CLASS-I): final results. Stroke 2001, 33:122-9.
9. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995, 333:1581-7.
10. Lyden PD, Shuaib A, Lees KR. Safety and tolerability of NXY-059 for acute intracerebral hemorrhage: the CHANT trial. Stroke 2007, 38:2262-9.
11. Lees KR, Zivin JA, Ashwood T. NXY-059 for acute ischemic stroke. N Engl J Med 2006, 354:588-600.
12. Hacke W, Kaste M, Fieschi C. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. JAMA 1995, 274:1017-25.
13. Shuaib A, Lees KR, Lyden P. NXY-059 for the treatment of acute ischemic stroke. N Engl J Med 2007, 357:562-71.
14. Hacke W, Kaste M, Fieschi C. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. Lancet 1998, 352:1245-51.
15. Davis SM, Albers GW, Diener HC, Lees KR, Norris J. Termination of acute stroke studies involving selfotel treatment. ASSIST steering committee. Lancet 1997, 349:32.
16. Sacco RL, DeRosa JT, Haley EC. Glycine antagonist in neuroprotection for patients with acute stroke: GAIN Americas: a randomized controlled trial. JAMA 2001, 285:1719-28.
17. Davis S, Lees K, Albers G. Selfotel in acute ischemic stroke. Possible neurotoxic effects of an nmda antagonist. Stroke 2000, 31:347-54.
18. Lees KR, Asplund K, Carolei A. Glycine antagonist (gavestinel) in neuroprotection (GAIN international) in patients with acute stroke: a randomised controlled trial. Lancet 2000, 355:1949-54.
19. Mendelow A, Gregson B, Fernandes H. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International Surgical Trial in Intracerebral Haemorrhage (STICH): a randomised trial. Lancet 2005, 365:387-97.
20. Muir KW, Lees KR, Ford I, Davis S. Magnesium for acute stroke (Intravenous Magnesium Efficacy in Stroke trial): randomised controlled trial. Lancet 2004, 363:439-45.
21. Bath PM, Lindenstrom E, Boysen G. Tinzaparin in acute ischaemic stroke (TAIST): a randomised aspirin-controlled trial. Lancet 2001, 358:702-10.
22. Wahlgren NG, MacMahon DG, De Keyser J, Indredavik B, Ryman T. Intravenous Nimodipine West European Stroke Trial (INWEST) of nimodipine in the treatment of acute ischaemic stroke. Cerebrovasc Dis 1994, 4:204-10.
23. Lyden PD. Systemic review of nimodipine. Stroke 2001, 32:2433-8.
24. Leonardi-Bee J, Bath PM, Phillips SJ, Sandercock PA. Blood pressure and clinical outcomes in the International Stroke Trial. Stroke 2002, 33:1315-20.
25. Sare GM, Ali M, Shuaib A, Bath PM. Relationship between hyperacute blood pressure and outcome after ischemic stroke: data from the VISTA collaboration. Stroke 2009, 40:2098-103.
26. Yong M, Diener HC, Kaste M, Mau J. Characteristics of blood pressure profiles as predictors of long-term outcome after acute ischemic stroke. Stroke 2005, 36:2619-25.
27. Saini M, Saqqur M, Kamruzzaman A, Lees KR, Shuaib A. Effect of hyperthermia on prognosis after acute ischemic stroke. Stroke 2009, 40:3051-9.
28. Grau AJ, Weimar C, Buggle F. Risk factors, outcome, and treatment in subtypes of ischemic stroke - The German Stroke Data Bank. Stroke 2001, 32:2559-66.
29. Hallevi H, Albright KC, Martin-Schild S, Barreto AD, Grotta JC, Savitz SI. The complications of cardioembolic stroke: lessons from the VISTA database. Cerebrovasc Dis 2008, 26:38-40.
30. Kamel H, Lees KR, Lyden PD. Delayed detection of atrial fibrillation after ischemic stroke. J Stroke Cerebrovasc Dis 2009, 18:453-7.
31. Gray LJ, Ali M, Lyden PD, Bath PM. Interconversion of the National Institutes of Health Stroke Scale and Scandinavian Stroke Scale in acute stroke. J Stroke Cerebrovasc Dis 2009, 18:466-8.
32. Adams RJ, Chimowitz MI, Alpert JS. Coronary risk evaluation in patients with transient ischemic attack and ischemic stroke: a scientific statement for healthcare professionals from the Stroke Council and the Council on Clinical Cardiology of the American Heart Association/American Stroke Association. Stroke 2003, 34:2310-22.
33. Weimar C, Roth MP, Zillessen G. Complications following acute ischemic stroke. Eur Neurol 2002, 48:133-40.
34. Prosser J, MacGregor L, Lees KR, Diener HC, Hacke W, Davis S. Predictors of early cardiac morbidity and mortality after ischemic stroke. Stroke 2007, 38:2295-302.
35. Di Legge S, Fang J, Saposnik G, Hachinski V. The impact of lesion side on acute stroke treatment. Neurology 2005, 65:81-6.
36. Foerch C, Misselwitz B, Sitzer M, Berger K, Steinmetz H, Neumann-Haefelin T. Difference in recognition of right and left hemispheric stroke. Lancet 2005, 366:392-3.
37. Fink JN, Frampton CM, Lyden P, Lees KR. Does hemispheric lateralization influence functional and cardiovascular outcomes after stroke? an analysis of placebo-treated patients from prospective acute stroke trials. Stroke 2008, 39:3335-40.
38. Weimar C, Koenig IR, Kraywinkel K, Ziegler A, Diener HC. Age and National Institutes of Health Stroke Scale Score within 6 hours after onset are accurate predictors of outcome after cerebral ischemia: development and external validation of prognostic models. Stroke 2004, 35:158-62.
39. Konig IR, Ziegler A, Bluhmki E. Predicting long-term outcome after acute ischemic stroke: a simple index works in patients from controlled clinical trials. Stroke 2008, 39:1821-6.
40. Hallevi H, Albright KC, Martin-Schild SB. Recovery after ischemic stroke: criteria for good outcome by level of disability at day 7. Cerebrovasc Dis 2009, 28:341-8.
41. Whitehead J, Bolland K, Valdes-Marquez E, Lihic A, Ali M, Lees K. Using historical lesion volume data in the design of a new phase II clinical trial in acute stroke. Stroke 2009, 40:1347-52.
42. Ali M, Sacco RL, Lees KR. Primary endpoint times, functional outcome and adverse event profile after acute ischaemic stroke. Int J Stroke 2009, 4:432-42.
43. Ali M, Atula S, Bath PM. Stroke outcome in clinical trial patients deriving from different countries. Stroke 2009, 40:35-40.
44. Vahedi K, Hofmeijer J, Juettler E. Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials. Lancet Neurol 2007, 6:215-22.
45. Juttler E, Schwab S, Schmiedek P. Decompressive surgery for the treatment of malignant infarction of the middle cerebral artery (DESTINY): a randomized, controlled trial. Stroke 2007, 38:2518-25.
46. Ali M, Jüttler E, Lees KR, Hacke W, Diedler J. Patient outcomes in historical comparators compared with randomised-controlled trials. Int J Stroke 2010, 5:10-5.
47. Ali M, Lyden P, Sacco RL, Shuaib A, Lees KR. Natural history of complications after intracerebral haemorrhage. Eur J Neurol 2009, 16:624-30.
48. Weimar C, Benemann J, Diener HC. Development and validation of the Essen Intracerebral Haemorrhage Score. J Neurol Neurosurg Psychiatry 2006, 77:601-5.
49. Weimar C, Roth M, Willig V, Kostopoulos P, Benemann J, Diener HC. Development and validation of a prognostic model to predict recovery following intracerebral hemorrhage. J Neurol 2006, 253:788-93.
50. Weimar C, Ziegler A, Sacco RL, Diener HC, Konig IR. Predicting recovery after intracerebral hemorrhage-an external validation in patients from controlled clinical trials. J Neurol 2009, 256:464-9.
51. Dawson J, Walters M. Uric acid and xanthine oxidase: future therapeutic targets in the prevention of cardiovascular disease? Br J Clin Pharmacol 2006, 62:633-44.
52. Dawson J, Lees KR, Weir CJ. Baseline serum urate and 90-day functional outcomes following acute ischemic stroke. Cerebrovasc Dis 2009, 28:202-3.
53. Quinn TJ, Dawson J, Lees JS, Chang TP, Walters MR, Lees KR. Time spent at home poststroke: " home-time" a meaningful and robust outcome measure for stroke trials. Stroke 2008, 39:231-3.